Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-266,043
Closed -$7.94M 34
2020
Q1
$7.94M Sell
266,043
-17,684
-6% -$756K 2.88% 22
2019
Q4
$12.2M Sell
283,727
-112,218
-28% -$4.65M 2.9% 20
2019
Q3
$14.9M Buy
395,945
+31,603
+9% +$1.14M 3.51% 7
2019
Q2
$13.8M Sell
364,342
-369,483
-50% -$12.3M 3.19% 14
2019
Q1
$21.8M Buy
733,825
+45,414
+7% +$1.36M 3.47% 11
2018
Q4
$18.2M Buy
688,411
+39,040
+6% +$1.19M 3.1% 16
2018
Q3
$21.2M Buy
649,371
+56,921
+10% +$1.88M 2.8% 21
2018
Q2
$19.6M Sell
592,450
-17,235
-3% -$591K 2.46% 23
2018
Q1
$21.7M Buy
+609,685
New +$22.5M 2.53% 24

Other funds holding ACM

M.D. Sass LLC's ACM Position: Q2 2020 in Review

M.D. Sass LLC sold out of Aecom (ACM) in Q2 2020, closing a stake of 266,043 shares — an estimated $7.94M sold.

M.D. Sass LLC first reported a position in ACM in Q1 2018 and held it in 9 quarters. The position peaked at $21.8M in Q1 2019. 318 funds tracked by Wall St. Rank hold ACM as of Q2 2020.

  • M.D. Sass LLC reported no remaining Aecom position as of Q2 2020 after selling out during the quarter.
  • M.D. Sass LLC sold 266,043 Aecom shares in Q2 2020, an estimated $7.94M.
  • M.D. Sass LLC first reported a position in Aecom in Q1 2018 and held it in 9 quarters.
  • M.D. Sass LLC's Aecom position peaked at $21.8M in Q1 2019.
  • 318 funds tracked by Wall St. Rank held Aecom as of Q2 2020.

Based on M.D. Sass LLC's 13F filing for Q2 2020, filed 10 Aug 2020.